<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>journal-jmsr</PublisherName>
      <JournalTitle>Journal of Medical and Surgical Research</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Vol. III, n 1</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>June, 2016</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>JMSR Oncology</ArticleType>
      <ArticleTitle>Radiological Appearances of Primary Central Nervous System Lymphoma (PCNSL)</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>215</FirstPage>
      <LastPage>222</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Y. A.</FirstName>
          <LastName>Lamrani</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>B.</FirstName>
          <LastName>Alami</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>A.</FirstName>
          <LastName>Housni</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>H. El</FirstName>
          <LastName>Fattach</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>M.</FirstName>
          <LastName>Boubbou</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>M.</FirstName>
          <LastName>Maaroufi</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Primary central nervous system lymphomas (PCNSL) are uncommon tumours, accounting for only 2% of primary brain tumors. Recently many investigators have showed interest in MRI characteristics for aiding in diagnosis and stratify prognosis.&#13;
&#13;
In this article, we aimed to review characteristic findings on traditional and advanced Imaging seen in immune competent patients with intracranial primary CNS lymphoma (PCNSL).&#13;
&#13;
CT scan and MRI examinations of 15 immunocompetent patients with biopsy-proven PCNSL were retrospectively evaluated. T1 and T2 signal characteristics as well as contrast enhancement features are described in all patients. Diffusion, perfusion and proton-MR-spectroscopy features are described in a subset of these patients.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Primary Central Nervous System Lymphomas (PCNSL), Radiological Appearances</Keywords>
      <URLs>
        <Abstract>https://journal-jmsr.net/ubijournal-v1copy/journals/abstract.php?article_id=4777&amp;title=Radiological Appearances of Primary Central Nervous System Lymphoma (PCNSL)</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>1. Ricard D, Idbaih A, Ducray F, Lahutte M, HoangXuan K, DelattreJY. Primary brain tumours in adults. The Lancet. 2012 Jun1;379(9830):1984-96.&#13;
&#13;
2. L.M. De Angelis, "Primary central nervous system lymphoma," Recent Results in Cancer Research, vol. 135, pp. 155-169, 1994.&#13;
&#13;
3. A. J. M. Ferreri, M. Reni, and E. Villa, "Primary central nervous system lymphoma in immunocompetent patients,"Cancer Treatment Reviews, vol. 21, no. 5, pp. 415-446, 1995.&#13;
&#13;
4. Tang YZ, Booth TC, Bhogal P, Malhotra A, Wilhelm T. Imaging of primarycentral nervous system lymphoma. ClinRadiol, 2011 Aug; 66(8):768-77.&#13;
&#13;
5. Kand;uuml;ker W, Nand;auml;gele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M,Herrlinger U. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005 Apr; 72(2):169-77.&#13;
&#13;
6. I. S. Haldorsen, A. Espeland, and E. M. Larsson, "Central nervoussystem lymphoma: characteristic findings on traditionaland advanced imaging," American Journal of Neuroradiology,vol. 32, no. 6, pp. 984-992, 2011.&#13;
&#13;
7. Osborn A G, Blaser SI, Salzman KL. Diagnostic imaging: brain. 1ST ED.Salt Lake City. Amirsys. 2004.&#13;
&#13;
8. Haldorsen IS, Krakenes J, Krossnes BK, et al. CT and MR imaging features ofprimary central nervous system lymphoma in Norway, 1989-2003. AJNRAm J Neuroradiol2009;30:744-51&#13;
&#13;
9. Weaver JD, Vinters HV, Koretz B, et al. Lymphomatosiscerebri presenting asrapidly progressive dementia. Neurologist 2007;13:150-53&#13;
&#13;
10. Coulon A, Lafitte F, Hoang-Xuan K, et al. Radiographic findings in 37 casesof primary CNS lymphoma in immunocompetent patients. EurRadiol2002;12:329-40&#13;
&#13;
11. Zacharia TT, Law M, Naidich TP, Leeds NE: Central nervous system lymphoma characterization by diffusion-weighted imaging and MRspectroscopy. J Neuroimaging 2008, 18:411- 17.&#13;
&#13;
12. Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394-403&#13;
&#13;
13. A. Doskaliyev, F. Yamasaki, M. Ohtaki et al., "Lymphomas and glioblastomas: differences in the apparent diffusion coefficientevaluated with high bvalue diffusion-weighted magnetic resonanceimaging at 3T," European Journal of Radiology, vol. 81, no.2, pp. 339-344, 2012.&#13;
&#13;
14. Barajas RF, Rubenstein JL, Chang JS, Hwang J, CHA S: Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive ofClinical Outcome in Primary Central Nervous System Lymphoma.AJNR Am J Neuroradiol 2010, 31(1):60-66.&#13;
&#13;
15. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonanceimaging. NeurosciLett 2003; 338:119-22&#13;
&#13;
16. Hakyemez B, Erdogan C, Bolca N, et al. Evaluation of different cerebral mass lesions by perfusionweighted MR imaging. J MagnReson Imaging 2006;24:817-24&#13;
&#13;
17. Tallibert S, Guillevin R, Menuel C, et al. Brain lymphoma: usefulness of themagnetic resonance spectroscopy. J Neurooncol 2008; 86(2):225-229.&#13;
&#13;
18. Asem Mansour, MontherQandeel, Hikmat AbdelRazeq and Hussain Ali Abu Ali. MR imaging features of intracranial primary CNS lymphoma in immune competent patients.Cancer Imaging 2014, 7;14:22&#13;
&#13;
19. T. Lim, S. J. Kim, K. Kim et al., "Primary CNS lymphoma other thanDLBCL: a descriptive analysis of clinical features and treatment outcomes," Annals of Hematology, vol. 90, no. 12, pp.1391-1398, 2011.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>